NeueHealth (NEUE) director Manders acquired 10,500 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Matthew G Manders (director at NeueHealth Inc., NEUE) reported that they acquired 10,500 shares on May 13, 2025. After these transactions the filing shows 16,741 shares held directly.
- Reporting person
- Manders Matthew G
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 13, 2025 | Exercise or conversion of a derivative (M) | Common Stock | +10,500 | - | - | 16,741 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 13, 2025 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 10,500 Common Stock1, 2 | -10,500 | - | - | 0 direct |
Holdings before and after
- Common Stock: 6,241 to 16,741 direct
- Restricted Stock Units: 10,500 to 0 direct
Footnotes from the filing
- 1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- 2. All of these restricted stock units vested on May 13, 2025, one year from the grant date.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Manders report in this NEUE Form 4?
Matthew G Manders (director at NeueHealth Inc., NEUE) reported that they acquired 10,500 shares on May 13, 2025. After these transactions the filing shows 16,741 shares held directly.
How many NEUE shares does Manders hold after this filing?
The filing shows 16,741 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for NEUE
Earlier insider filings at NEUE
- May 15, 2025Director Slavitt Andrew M converted options into 10,500 shares, increasing direct ownership by 131% to 18,529 units (SEC Form 4)
- May 14, 2025Chief Accounting Officer Scherman Jeffrey J sold $757 worth of shares (112 units at $6.76), decreasing direct ownership by 0.89% to 12,463 units (SEC Form 4)
- May 14, 2025Chief Financial Officer Matushak Jay sold $3,191 worth of shares (472 units at $6.76), decreasing direct ownership by 1% to 40,556 units (SEC Form 4)
- May 13, 2025Chief Accounting Officer Scherman Jeffrey J converted options into 341 shares, increasing direct ownership by 3% to 12,575 units (SEC Form 4)
- May 13, 2025Chief Financial Officer Matushak Jay converted options into 978 shares, increasing direct ownership by 2% to 41,028 units (SEC Form 4)
Quantisnow market dataNYSE
NEUE
NeueHealth Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
- Listed since
- 2021
Get push alerts for NEUE
Full NEUE profile on Quantisnow Follow NEUE and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time